Journey Strategic Wealth’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$910K Sell
8,867
-1,876
-17% -$212K 0.02% 203
2025
Q4
$1.35M Sell
10,743
-2,221
-17% -$283K 0.04% 134
2025
Q3
$1.74M Sell
12,964
-1,546
-11% -$203K 0.05% 106
2025
Q2
$1.97M Buy
14,510
+9,093
+168% +$1.2M 0.06% 95
2025
Q1
$719K Buy
5,417
+519
+11% +$66.1K 0.03% 175
2024
Q4
$554K Buy
4,898
+26
+0.5% +$3K 0.02% 198
2024
Q3
$556K Buy
4,872
+1,135
+30% +$124K 0.02% 202
2024
Q2
$388K Buy
3,737
+1,444
+63% +$153K 0.02% 201
2024
Q1
$261K Buy
+2,293
New +$263K 0.01% 219
2023
Q2
Sell
-3,127
Closed -$317K 202
2023
Q1
$317K Sell
3,127
-1,922
-38% -$203K 0.03% 148
2022
Q4
$554K Buy
5,049
+1,708
+51% +$177K 0.07% 89
2022
Q3
$324K Buy
+3,341
New +$356K 0.04% 98
2022
Q2
Sell
-4,173
Closed -$494K 128
2022
Q1
$494K Buy
4,173
+69
+2% +$8.55K 0.05% 53
2021
Q4
$578K Buy
+4,104
New +$525K 0.06% 61

Other funds holding ABT

Journey Strategic Wealth's ABT Position: Q1 2026 in Review

Journey Strategic Wealth reduced its Abbott (ABT) stake by 17% in Q1 2026, selling an estimated $212K and leaving 8,867 shares worth $910K. The position accounts for 0.02% of the portfolio, ranked #203.

Journey Strategic Wealth first reported a position in ABT in Q4 2021 and has held it in 14 quarters since. The position peaked at $1.97M in Q2 2025. 3,089 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Journey Strategic Wealth held 8,867 shares of Abbott worth $910K as of Q1 2026.
  • Journey Strategic Wealth sold 1,876 Abbott shares in Q1 2026, an estimated $212K.
  • Abbott made up 0.02% of Journey Strategic Wealth's portfolio in Q1 2026, its #203 holding.
  • Journey Strategic Wealth first reported a position in Abbott in Q4 2021 and has held it in 14 quarters since.
  • Journey Strategic Wealth's Abbott position peaked at $1.97M in Q2 2025.
  • 3,089 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.